Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[New treatment options in multiple sclerosis and their complications].
Melanoma complicating treatment with natalizumab for multiple sclerosis.
Self-tolerance in multiple sclerosis.
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
The dynamics of finger tremor in multiple sclerosis is affected by whole body position.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
"People power" or "pester power"? YouTube as a forum for the generation of evidence and patient advocacy.
Reduced R2' in multiple sclerosis normal appearing white matter and lesions may reflect decreased myelin and iron content.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
TH17 cell differentiation is regulated by the circadian clock.
Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Optical Coherence Tomography Detection of Neurodegeneration in Multiple Sclerosis.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
Pages
« first
‹ previous
…
197
198
199
200
201
202
203
204
205
…
next ›
last »